ZA879754B - Method of inhibiting interleukin-1 activity - Google Patents

Method of inhibiting interleukin-1 activity

Info

Publication number
ZA879754B
ZA879754B ZA879754A ZA879754A ZA879754B ZA 879754 B ZA879754 B ZA 879754B ZA 879754 A ZA879754 A ZA 879754A ZA 879754 A ZA879754 A ZA 879754A ZA 879754 B ZA879754 B ZA 879754B
Authority
ZA
South Africa
Prior art keywords
activity
inhibiting interleukin
interleukin
inhibiting
alleviation
Prior art date
Application number
ZA879754A
Other languages
English (en)
Inventor
Gerald L Mandell
L Mandell Gerald
Gail W Sullivan
W Sullivan Gail
William J Novick Jr
J Novick William Jr
Original Assignee
Hoechst Roussel Pharma
Univ Virginia Alumni Patent Fo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma, Univ Virginia Alumni Patent Fo filed Critical Hoechst Roussel Pharma
Publication of ZA879754B publication Critical patent/ZA879754B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45Transferases (2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA879754A 1986-12-31 1987-12-30 Method of inhibiting interleukin-1 activity ZA879754B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94790586A 1986-12-31 1986-12-31

Publications (1)

Publication Number Publication Date
ZA879754B true ZA879754B (en) 1989-07-26

Family

ID=25486973

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA879754A ZA879754B (en) 1986-12-31 1987-12-30 Method of inhibiting interleukin-1 activity

Country Status (14)

Country Link
EP (1) EP0279079B1 (ko)
JP (1) JP2507012B2 (ko)
KR (1) KR960015726B1 (ko)
AT (1) ATE151290T1 (ko)
AU (1) AU668982B2 (ko)
CA (1) CA1313137C (ko)
DE (1) DE3752048T2 (ko)
DK (1) DK482088A (ko)
ES (1) ES2103255T3 (ko)
GR (1) GR3024054T3 (ko)
IE (1) IE873554L (ko)
IL (7) IL100536A (ko)
WO (1) WO1988004928A1 (ko)
ZA (1) ZA879754B (ko)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196429A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5196430A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5272153A (en) * 1986-12-31 1993-12-21 Hoechst-Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
JPH04506215A (ja) * 1989-06-13 1992-10-29 スミスクライン・ビーチャム・コーポレイション モノカイン活性干渉
DD298051A5 (de) * 1989-08-16 1992-02-06 ��@���������@�������k�� Verfahren zur herstellung eines therapeutischen agens zur behandlung von verdauungskrankheiten
EP0493682A3 (en) * 1990-11-30 1992-11-19 Hoechst-Roussel Pharmaceuticals Incorporated Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans
EP0490181A1 (en) * 1990-11-30 1992-06-17 Hoechst-Roussel Pharmaceuticals Incorporated Use of xanthines for preparation of a medicament having immunosuppressing activity
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
WO1992021344A2 (en) * 1991-05-24 1992-12-10 Fred Hutchinson Cancer Research Center Modulation of cellular response to external stimuli
JPH05194233A (ja) * 1991-06-10 1993-08-03 Hoechst Roussel Pharmaceut Inc マイクロペレットおよびそれらの製造方法
WO1993003728A1 (en) * 1991-08-27 1993-03-04 Temple University Of The Commonwealth System Of Xanthine suppression of antigen activation of t- or b-cells
ES2173871T3 (es) * 1991-10-31 2002-11-01 Univ Manchester Tratamiento de condiciones neurologicas por un compuesto inhibidor de la interleukina-1.
WO1996005836A2 (en) * 1994-08-25 1996-02-29 Medical University Of South Carolina Methods of treating cold symptoms using pentoxifylline
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
JP3830115B2 (ja) * 1997-10-06 2006-10-04 シャープ株式会社 液晶表示素子
TW561297B (en) * 1997-11-25 2003-11-11 Toshiba Corp Electrode wiring board subjected to counter measure against static electricity and display device using the same
JP3019053B2 (ja) * 1997-12-25 2000-03-13 日本電気株式会社 液晶表示装置及びその製造方法
BRPI0908107A2 (pt) 2008-02-29 2019-09-24 Concert Pharmaceuticals Inc composto derivado de xantina substituída, composição farmacêutica que compreende esse composto, métodos de tratamento de uma enfermidade ou condição em um paciente com necessidade do mesmo, método de tratamento de enfermidade crônica dos rins, do fígado, relacionada com diabetes e de claudicação intermitente
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
CA2771331A1 (en) 2009-09-02 2011-03-10 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
WO2012031138A2 (en) 2010-09-01 2012-03-08 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3-7-dimethyl-1h-purine-2,6(3h,7h)dione
WO2013013052A1 (en) 2011-07-19 2013-01-24 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
WO2013155465A1 (en) 2012-04-13 2013-10-17 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
WO2013159006A1 (en) 2012-04-20 2013-10-24 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3,7-dimethyl-1h-purine-2,6(3h,7h)-dione

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2967632D1 (en) * 1978-04-22 1986-12-04 Beecham Wuelfing Gmbh & Co Kg Use of a xanthine derivate in the manufacture of a medicament
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
GB8418430D0 (en) * 1984-07-19 1984-08-22 Beecham Wuelfing Gmbh & Co Kg Treatment

Also Published As

Publication number Publication date
AU4602793A (en) 1993-11-18
EP0279079A2 (en) 1988-08-24
ATE151290T1 (de) 1997-04-15
GR3024054T3 (en) 1997-10-31
DE3752048T2 (de) 1997-10-02
IE873554L (en) 1988-06-30
DK482088D0 (da) 1988-08-30
DK482088A (da) 1988-10-28
JPH02501829A (ja) 1990-06-21
IL100533A (en) 1994-05-30
KR890700347A (ko) 1989-04-24
JP2507012B2 (ja) 1996-06-12
DE3752048D1 (de) 1997-05-15
CA1313137C (en) 1993-01-26
AU668982B2 (en) 1996-05-23
IL100535A (en) 1994-05-30
EP0279079A3 (en) 1990-06-13
AU637542B2 (en) 1993-05-27
WO1988004928A1 (en) 1988-07-14
ES2103255T3 (es) 1997-09-16
IL106859A (en) 1996-10-16
EP0279079B1 (en) 1997-04-09
IL106861A (en) 1997-02-18
AU1150588A (en) 1988-07-27
IL106854A (en) 1996-05-14
AU619732B2 (en) 1992-02-06
IL100536A (en) 1994-05-30
AU1291892A (en) 1992-05-14
IL84934A (en) 1994-08-26
KR960015726B1 (ko) 1996-11-20

Similar Documents

Publication Publication Date Title
IE873554L (en) Method of inhibiting interleukin-1 activity
IT8547927A0 (it) Composizione farmaceutica contenente un composto beta-bloccante per la profilassi ed il trattamento di disordini cardiaci
BR8500069A (pt) Tipo mutante de bacteria
ATE86960T1 (de) Cyclopropanderivate.
PT80713A (en) Aryl derivatives of heterobicyclic compounds
FR2576577B1 (fr) Plate-forme semi-submersible de production petroliere, de stockage et de chargement en eau profonde
FR2580209B1 (fr) Procede de fabrication d'outils de decoupage et outils de decoupage fabriques par ledit procede
IT1181659B (it) Procedimento per l'elaborazione di segnali modem
IL75430A0 (en) Pineapple ketone carbonate derivatives and their use as flavoring agents
ZW15387A1 (en) Dopamine-b-hydroxylase inhibitors
ZA854841B (en) Aryl derivatives of heterobicyclic compounds
IT8823156A0 (it) Impianto per la depurazione meccanico-biologica di acque di rifiuto
IT1175808B (it) Procedimento per la preparazione di composto con attivita' antiulcera
GB8522174D0 (en) Production of oxygenated organic compounds
IE872207L (en) Inhibition of interleukin-1 production
IT8622389A0 (it) Procedimento per la preparazione di composti ad attivita' anti ulcera
KR890001929U (ko) 수심에 따라 자동 조절되는 낚시찌
GB8723816D0 (en) Cabburation of water into i c engine
IT1173244B (it) Procedimento per preparare il 7-(alfa-solfofenilacetamido)-3-(4'-carbamoilpiridinio)metil-3-cefem-4-carbossilato
GB8621569D0 (en) Production of oxygenated organic compounds
KR860005495U (ko) 관상어용 여과판의 산소공급관
KR880011754U (ko) 파이프 공급기의 파이프 공급 장치
KR890001889U (ko) 콩나물 재배상의 용수 분배판
GB8421648D0 (en) Optimizing effectiveness of grip of screw &c
AU91496S (en) Nest of tables